UK markets closed

MediPharm Labs Corp (MLZ.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0442-0.0002 (-0.45%)
At close: 07:26PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-46,140
-13,083
-29,983
-54,801
-66,353
Depreciation & amortisation
4,715
2,516
2,872
5,633
10,807
Deferred income taxes
7
-
-6
113
-4,990
Stock-based compensation
2,093
2,027
2,872
2,402
2,681
Change in working capital
20,154
3,450
6,239
6,355
17,180
Accounts receivable
6,291
6,291
3,618
5,932
-2,089
Inventory
8,389
3,114
-103
2,485
29,408
Other working capital
-20,706
-12,810
-16,932
-13,996
-45,276
Other non-cash items
-493
-7,345
-483
10,281
7,602
Net cash provided by operating activities
-19,946
-12,339
-16,069
-13,213
-37,773
Cash flows from investing activities
Investments in property, plant and equipment
-760
-471
-863
-783
-7,503
Purchases of investments
-
-
-
0
-2
Other investing activities
1,903
1,903
7
507
-
Net cash used for investing activities
-267
6,872
5,158
35
-7,446
Cash flows from financing activities
Debt repayment
-491
-2,010
-948
-2,962
-14,061
Common stock issued
0
-
0
30,917
0
Dividends paid
0
0
0
0
0
Other financing activities
358
840
429
-139
-327
Net cash used provided by (used for) financing activities
1,196
-368
796
27,804
26,422
Net change in cash
-18,504
-6,164
-9,965
14,197
-18,714
Cash at beginning of period
37,958
24,145
34,110
19,913
38,627
Cash at end of period
18,941
17,981
24,145
34,110
19,913
Free cash flow
Operating cash flow
-19,946
-12,339
-16,069
-13,213
-37,773
Capital expenditure
-760
-471
-863
-783
-7,503
Free cash flow
-20,706
-12,810
-16,932
-13,996
-45,276